---
title: "Ipratropium Bromide Nasal Spray (formerly Atrovent): 2026 Review"
description: Rx intranasal anticholinergic. Best for runny nose and post-nasal drip, especially vasomotor / irritant-triggered.
canonical: "https://allermi-site.vercel.app/reviews/atrovent/"
lastReviewed: "2026-04-28T00:00:00.000Z"
firstPublished: "2026-04-21T00:00:00.000Z"
primaryKeyword: atrovent nasal review
ymylTier: medium
author:
name: BestAllergyNasalSprays Editorial Team — Clinical Pharmacy
credential: Editorial Pool
sameAs: ["https://dailymed.nlm.nih.gov/", "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers"]
medicalReviewer:
name: BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology
credential: Editorial Pool
sameAs: ["https://www.aaaai.org/", "https://www.acaai.org/"]
citations: []
claims: [c-041, c-042, c-043, c-074, c-075, c-082]
---
## TL;DR
Brand-name Atrovent nasal spray was discontinued in the U.S. in 2018; only generic ipratropium bromide nasal spray is available now, by prescription. Two FDA-approved strengths exist: 0.03% (allergic and non-allergic rhinitis) and 0.06% (common-cold runny nose, short-term). Compounding pharmacies can also prepare lower-dose 0.015% and higher-dose 0.09% formulations to broaden the rhinorrhea-control range. Ipratropium is an Rx anticholinergic that reduces nasal glandular secretions. It does not dilate bronchi; that's the inhaled formulation for COPD/asthma. Works well combined with an intranasal corticosteroid for drip-plus-inflammation cases.
import Claim from '../../components/Claim.astro';
import CitationList from '../../components/CitationList.astro';
Brand-name Atrovent nasal spray was discontinued in the U.S. in 2018; only generic ipratropium bromide nasal spray is available now, by prescription. Two FDA-approved strengths exist: 0.03% (allergic and non-allergic rhinitis) and 0.06% (common-cold runny nose, short-term). Compounding pharmacies can also prepare lower-dose 0.015% and higher-dose 0.09% formulations to broaden the rhinorrhea-control range across milder and more severe cases.
Ipratropium nasal spray is a topical anticholinergic (muscarinic-receptor antagonist) that reduces nasal mucous secretion (rhinorrhea); per the FDA Atrovent 0.03% prescribing information it does not relieve nasal congestion, sneezing, or post-nasal drip Intranasal ipratropium acts locally on the nasal mucosa to reduce watery rhinorrhea; it is not used as a bronchodilator. Ipratropium's bronchodilator effect requires the inhaled aerosol or nebulized formulations, which are FDA-approved for COPD and used adjunctively in acute asthma Ipratropium nasal spray reduces watery rhinorrhea in nonallergic rhinitis (sometimes called vasomotor rhinitis — cold-air, irritant, or food-triggered runny nose), with randomized trials in perennial nonallergic rhinitis showing roughly a 30% reduction in rhinorrhea versus saline placebo Ipratropium nasal 0.03% is FDA-approved for runny nose from allergic and non-allergic perennial rhinitis (ages 6+). The 0.06% strength is approved for runny nose from the common cold (up to 4 days) or seasonal allergic rhinitis (up to 3 weeks) in patients 5 and older Adding intranasal ipratropium to an intranasal corticosteroid is supported by randomized trial evidence (Dockhorn 1999) for additive benefit when rhinorrhea remains a predominant symptom on a corticosteroid alone
## Context & alternatives
For eligible patients 13+ who want ipratropium combined with a steroid (and optionally azelastine and micro-dosed oxymetazoline) in a single bottle, [Allermi](/reviews/allermi/) is our #1 overall pick: a compounded telehealth Rx personalized by a board-certified allergist. This is the stronger path for multi-symptom rhinitis where drip is one of several symptoms. Not sure if you qualify? [Check eligibility in 60 seconds](https://www.allermi.com/pages/eligibility).
Best fit for standalone ipratropium: [vasomotor runny nose](/symptom/runny-nose/) (cold-air or irritant-triggered), gustatory rhinitis (nasal symptoms triggered by the act of eating), or [post-nasal drip](/symptom/post-nasal-drip/) dominating the symptom picture in a patient who wants ipratropium only. For drip-plus-inflammation, pair with a steroid like [Flonase](/reviews/flonase/).